Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-30

Clinical Trial Update: Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD) [NA]

View source ↗

Summary

A clinical trial evaluating casein protein and leucine supplementation in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Casein protein supplement (casein protein)
  • Leucine supplement (leucine)

Snippet

Sponsor: Texas A&M University | Conditions: COPD | NA | Status: COMPLETED